![Bioequivalence study of cyclizine hydrochloride 50 mg tablets in healthy volunteers: a randomized, open-label, single-dose study. | Semantic Scholar Bioequivalence study of cyclizine hydrochloride 50 mg tablets in healthy volunteers: a randomized, open-label, single-dose study. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/662927e7a0dc980cecbc3aeb79c4ed9a9bb25932/6-Table3-1.png)
Bioequivalence study of cyclizine hydrochloride 50 mg tablets in healthy volunteers: a randomized, open-label, single-dose study. | Semantic Scholar
![Prevention of postoperative nausea and vomiting after spinal morphine for Caesarean section: comparison of cyclizine, dexamethasone and placebo - British Journal of Anaesthesia Prevention of postoperative nausea and vomiting after spinal morphine for Caesarean section: comparison of cyclizine, dexamethasone and placebo - British Journal of Anaesthesia](https://www.bjanaesthesia.org.uk/cms/attachment/2109116654/2082784228/gr1.jpg)
Prevention of postoperative nausea and vomiting after spinal morphine for Caesarean section: comparison of cyclizine, dexamethasone and placebo - British Journal of Anaesthesia
![Cyclizine | Marzine /Nausin |Mechanism of Action |Dosage| Indications |Adverse Effect(Urdu/Hindi) - YouTube Cyclizine | Marzine /Nausin |Mechanism of Action |Dosage| Indications |Adverse Effect(Urdu/Hindi) - YouTube](https://i.ytimg.com/vi/EppVmQVVwSg/mqdefault.jpg)
Cyclizine | Marzine /Nausin |Mechanism of Action |Dosage| Indications |Adverse Effect(Urdu/Hindi) - YouTube
A comparison of triprolidine and cyclizine on histamine (H1) antagonism, subjective effects and performance tests in man. - Abstract - Europe PMC
![Bioequivalence study of cyclizine hydrochloride 50 mg tablets in healthy volunteers: a randomized, open-label, single-dose study. | Semantic Scholar Bioequivalence study of cyclizine hydrochloride 50 mg tablets in healthy volunteers: a randomized, open-label, single-dose study. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/662927e7a0dc980cecbc3aeb79c4ed9a9bb25932/5-Figure1-1.png)